A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Alpha Tau Medical LTD.
HiFiBiO Therapeutics
Novartis
3B Pharmaceuticals GmbH
Telix Pharmaceuticals (Innovations) Pty Limited
Eli Lilly and Company
Ipsen
Nektar Therapeutics
MacroGenics
Eli Lilly and Company
Seagen Inc.
Daiichi Sankyo
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center